Full-Time

Manager – Global Drug Safety & Pharmacovigilance

Updated on 9/9/2026

Celgard

Celgard

201-500 employees

High-performance membranes for energy storage

Compensation Overview

$120k - $130k/yr

+ Performance-based bonus eligibility

Cary, NC, USA

Hybrid

Hybrid work arrangement; approximately 10% travel required.

Bachelor's

Category
Biology & Biotech
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
Microsoft Outlook

Get referred to Celgard

See people who can refer or advise you

Requirements
  • A bachelor's degree in life sciences, nursing, pharmacy, or a related healthcare profession with relevant experience is required.
  • At least 5 years of pharmaceutical industry drug safety and pharmacovigilance experience involving development and post-marketed products is required.
  • Solid vendor management or contract research organization pharmacovigilance project management experience is required, including safety management plan preparation, establishment of key performance indicators and metrics, and contract management.
  • Strong knowledge of individual case safety report processing and the adverse event lifecycle is required.
  • Solid experience with drug safety databases is required, especially with Argus.
  • The ability to independently identify, analyze, and solve complex operational and data-related issues is required.
  • Strong understanding of current pharmacovigilance practices and global pharmacovigilance regulations, including regulatory reporting requirements, is required.
  • The ability to prioritize and plan effectively in a detail-oriented role is required.
  • Excellent written and verbal communication skills are required.
  • The ability to work independently and within a matrixed team in a dynamic, fast-paced environment with shifting priorities is required.
  • Proficiency in Microsoft Office applications, including Word, Excel, PowerPoint, and Outlook, and Adobe Pro is required.
Responsibilities
  • Serve as a resource and contact for company functions regarding pharmacovigilance operational activities.
  • Oversee vendor performance and vendor service outputs, including timely and on-budget delivery.
  • Oversee the United States adverse-event call center.
  • Oversee outsourced adverse-event processing, including review and monitoring of compliance through monitoring reports and key performance indicators.
  • Participate in quality audits of individual case safety reports following vendor processing, focusing on narrative accuracy against source documentation, Medical Dictionary for Regulatory Activities coding, expectedness against reference safety information, and appropriateness of follow-up queries to clinical sites or reporters.
  • Oversee adverse-event reconciliation between safety and clinical databases and adverse events exchanged between licensing partners.
  • Review safety-related sections of aggregate reports, including DSUR, PSUR/PBRER, PADER, and RMP.
  • Review and approve pharmacovigilance-related documents submitted to the Trial Master File.
  • Provide project-specific training to vendors.
  • Collaborate with vendors to develop Safety Management Plans and related forms and templates.
  • Collaborate with vendors to develop process-related documents to improve and standardize new processes.
  • Maintain knowledge of safety systems.
  • Assist in creating and maintaining standard operating procedures and working practices to ensure inspection readiness and regulatory compliance.
  • Support internal and external audits and regulatory inspections.
  • Assist with management of pharmacovigilance vendor contracts and forecasting activities.
  • Assist with management of license-partner safety data exchange agreements.
  • Assist management in establishing and coordinating product safety operations in accordance with regulations and company policies and procedures.
  • Assist in preparing and reviewing regulatory submissions, including safety reports and aggregate or periodic reports.
  • Represent the company in product safety meetings with cross-functional teams, licensing partners, and contract safety organizations.
  • Provide training to company personnel and third parties on pharmacovigilance requirements and compliance.
  • Maintain current knowledge of regulations and regulatory guidelines in the United States, Europe, and Japan.
Desired Qualifications
  • Argus experience is preferred.
  • Data migration experience is preferred.

Celgard makes and sells high-performance membrane materials and thin separators used inside batteries, as well as fabrics for outdoor apparel and medical PPE. The membranes sit between battery electrodes to prevent contact while allowing ions to pass, enabling safe and efficient operation in lithium-ion and other chemistries. The company stands out through its Asahi Kasei Group affiliation and strategic alliances (such as with Æsir Technologies) to pursue new battery chemistries, while expanding manufacturing capacity. Its goal is to provide reliable membranes and protective fabrics at scale to support safer, longer-lasting energy storage and protective textiles, and to drive industry growth through collaborations.

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

Charlotte, North Carolina

Founded

N/A

Get referred to Celgard

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Celgard launched new Concord coating capabilities on May 26, 2026, widening product customization.
  • Asahi Kasei opened Charlotte wet-process coating on August 20, 2026, expanding addressable battery demand.
  • Lithion Battery alliance and Toyota-linked North Carolina expansion deepen ESS and EV customer exposure.

What critics are saying

  • Asahi Kasei sold Daramic in December 2025, narrowing separator portfolio and strategic flexibility.
  • Celgard’s 2023–2025 Senior, Targray, and MTI litigation signals persistent IP leakage pressure.
  • Chinese separator rivals can commoditize coated separators, eroding Celgard pricing by 2027.

What makes Celgard unique

  • Celgard invented ceramic-coated separators, still central to lithium-ion safety performance.
  • Charlotte and Concord give Celgard U.S.-based dry-process and wet-process separator capacity.
  • Asahi Kasei’s 2026 North Carolina buildout leverages Celgard’s workforce and installed manufacturing base.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Company News

Shalimar Infotech Pvt Ltd
Aug 26th, 2026
Asahi Kasei unveils new wet-process separator coating line in North Carolina, advancing the company's 40-year North American Battery Separator strategy.

Asahi Kasei unveils new wet-process separator coating line in North Carolina, advancing the company's 40-year North American Battery Separator strategy. 26 Aug 2026 Asahi Kasei held a grand opening ceremony on August 20 for its new Hipore(TM) wet-process lithium-ion battery separator coating line in Charlotte, North Carolina, marking a significant milestone in the execution of the company's North American battery separator strategy. The investment expands production capacity at the company's existing Celgard manufacturing facility, establishing North America-based coating and supply capabilities for its wet-process separator technology. The facility represents the first step toward establishing a regional supply structure for wet-process separators. The investment decision was made in 2023, and commercial production is scheduled to begin in the second half of fiscal 2026. The grand opening coincided with the 40th anniversary of the Celgard manufacturing facility in Charlotte, which has been producing dry-process separators in the United States since 1986. The ceremony brought together local government officials, representatives of Toyota Tsusho Corporation, which has entered into a capacity rights agreement related to the facility, and other stakeholders who supported the project's development. The investment comes as North American battery demand is expected to expand beyond electric vehicles, supported by the increasing deployment of energy storage systems. Although the separator market remains competitive, improving regional market conditions are creating opportunities for suppliers with localized production and responsive supply capabilities. "Opening the Charlotte coating line is a key milestone in establishing our North American supply platform for battery separators," said Ryu Taniguchi, President of Asahi Kasei Battery Separator Corporation. "By leveraging Celgard's experienced workforce and established operations, we are expanding our North American product portfolio to include both dry-process and Hipore(TM) wet-process technologies. Together with our planned separator facility in Canada, this investment will bring production capabilities closer to the region's battery market and position Asahi Kasei to swiftly respond as demand grows across electric vehicles and energy storage systems." Construction of Asahi Kasei's wet-process separator facility in Canada is also progressing according to plan. Together, the Charlotte coating line and the Canadian plant will establish a regional supply framework for wet-process separators, strengthening the company's manufacturing presence and market position in North America. The investments support Asahi Kasei's broader growth strategy for Energy & Infrastructure, which is designated as a Growth Potential area of business under the company's medium-term management plan. About Asahi Kasei Asahi Kasei is a diversified global company that contributes to life and living for people around the world. Since its foundation in 1922, with businesses in ammonia and cellulose fiber, Asahi Kasei has consistently grown through proactive portfolio transformation to meet the evolving needs of every age. With 50,000 employees worldwide, the company contributes to sustainability by providing solutions to the world's challenges across its three business sectors: Healthcare, Homes, and Material.

Best Magazine
May 26th, 2026
Celgard celebrates 15 years at Concord site, expands separator coating capability.

Celgard celebrates 15 years at Concord site, expands separator coating capability. 26 May 2026 Celgard has launched new coating capabilities at its Concord, North Carolina manufacturing facility as the lithium-ion battery separator manufacturer marked the site's 15th anniversary. The company said the expansion adds new "state-of-the-art" coating technology capable of producing functional coatings, multilayer coated separators (MCS) and other customised separator products for lithium-ion batteries. According to the company, its new capabilities support a range of coating patterns, thicknesses, coverage levels and multilayer structures, while remaining compatible with multiple base-film technologies. The company said this would enable the development of more tailored separator products for electric vehicles, stationary energy storage systems and next-generation battery applications. Celgard's second US manufacturing site. The Concord plant opened in 2011 as Celgard's second US manufacturing site and forms part of the company's North American manufacturing network. The announcement comes amid the separation of Celgard and lead-acid battery separator specialist Daramic following the sale of Daramic by parent company Asahi Kasei. Celgard describes itself as the original inventor of ceramic-coated separators (CCS), a technology widely used in lithium-ion batteries to improve thermal stability and safety performance. "With our global footprint especially deeply rooted in US, we are excited to drive the LIB industry to a new level with our partners," the company said. Photo: Employees at the Concord facility were joined by local business leaders and government representatives for a ribbon-cutting ceremony marking the launch of the new coating capabilities. Credit: Celgard

Yahoo Finance
Jan 29th, 2024
Celgard and Æsir Technologies Forge Strategic Alliance to Drive Industry Innovation in Nickel-Zinc, Zinc-Air and Lithium-Zinc Batteries

Together, Celgard and Æsir will collaborate on joint research projects to further develop high-technology next-generation Nickel-Zinc (Ni-Zn), Zinc-Air (Zn-Air), Lithium-Zinc (Li-Zn) and Sodium-Zinc (Na-Zn) batteries used primarily in aviation, data centers, telecom, energy infrastructure and electric vehicle (EV) charging applications.

Plant Services
Nov 30th, 2023
Celgard expands North Carolina manufacturing plant to support electric vehicle supply chain

Celgard, LLC has announced plans to expand its manufacturing facility in Charlotte, North Carolina, generating 100 new jobs in the process.

PR Newswire
Oct 31st, 2023
Celgard Charlotte Manufacturing Facility To Expand Battery Separator Capacity And Create New Jobs

Celgard to expand facilities, workforce and product portfolio to better serve the EV battery separator supply chain. Post thisThe Biden-Harris Administration and the U.S. Department of Energy (DOE) have identified the domestic U.S. battery market as a critical supply chain focus area for the nation. Investments in Celgard's Charlotte plant will allow the company to expand existing infrastructure to quickly meet demand of the lithium-ion battery (LIB) separator supply chain and domestic customers.Celgard manufactures dry-process membrane separator also used in vehicle electrification. The company already has a skilled employee base capable of applying technical coatings to base film shipped from Hipore™ sister locations and completing finishing steps required to meet customer specifications